Related Experiment Videos

Molecular markers and stem-cell transplants: are they made for each other?

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|May 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Gynecologic oncology·2021

Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion.

Oncogene·2013

A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study.

Gynecologic oncology·2013

A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies.

Annals of oncology : official journal of the European Society for Medical Oncology·2008

Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

See all related articles